Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_assertion description "[Other chemotherapeutic drugs such as vinorelbine (Navelbine) and SN38 (the potent active metabolite of irinotecan) combined with OBP-401 also inhibited the growth of human cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_assertion evidence source_evidence_literature NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_assertion SIO_000772 16477640 NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_assertion wasDerivedFrom befree-20150227 NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_assertion wasGeneratedBy ECO_0000203 NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP895630.RALfv2k85vPh5P4l9gr89ioPyTP02ua5hIIVbCRV4XTj4130_provenance.